InvestorsHub Logo
Followers 8
Posts 1894
Boards Moderated 0
Alias Born 05/05/2016

Re: None

Wednesday, 01/30/2019 3:11:02 PM

Wednesday, January 30, 2019 3:11:02 PM

Post# of 17567
The "mixed result" nonsense seems to have blotted out simple commons sense! A medication with similar comfort levels and MUCH better efficacy, so that the primary goal, relief from DES symptoms is faster, seems to me to win at all around. The "mixed result" crowd doesn't understand the obvious, that faster relief is a measure of "comfort".

Silly article:
https://finance.yahoo.com/news/aurinia-pharmaceuticals-buy-193321889.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News